PATH

Call Directions Website

PATH PATH is a global nonprofit making good health easier to access in low-resource settings.

With nearly 50 years of experience forging multisector partnerships, and with expertise in science, economics, technology, advocacy, and dozens of other specialties, we develop and scale up innovative solutions to the world’s most pressing health challenges.

In Vietnam, rotavirus is one of the leading causes of severe, dehydrating diarrhea in children. The best way to prevent ...
10/16/2026

In Vietnam, rotavirus is one of the leading causes of severe, dehydrating diarrhea in children. The best way to prevent illness: vaccination. Given the country’s growing health care demands, the cost-effectiveness of new vaccine programs is a key factor in policy decisions.

PATH partnered with Vietnam’s National Institute of Hygiene and Epidemiology (Viện Vệ sinh dịch tễ Trung ương) and the London School of Hygiene & Tropical Medicine to evaluate the impact and cost-effectiveness of a nationwide rotavirus vaccine rollout.

The study results, recently published in Vaccine, provide compelling evidence in favor of this immunization decision. The national introduction of the domestically produced vaccine ROTAVIN® in Vietnam is expected to substantially reduce rotavirus cases, deaths, and associated health care costs.

What does it take to make digital health work in India? PATH is working with governments and partners in Andhra Pradesh,...
10/15/2026

What does it take to make digital health work in India?

PATH is working with governments and partners in Andhra Pradesh, Maharashtra, and Odisha to implement digital solutions that make it easier for people to deliver and receive health care.

In our latest article, team members share experiences from the field and reflect on what it takes to make digital health relevant, usable, and sustainable.

10/13/2026

Reframing noncommunicable diseases from an isolated health challenge into an urgent economic imperative is rapidly rewriting the global development agenda. While NCDs claim over 40 million lives annually and drain GDP in low- and middle-income countries, they receive barely 2% of official development assistance for health.

Ahead of the World Bank Group and International Monetary Fund annual meetings, Devex sat down with Kimberly Green, global director for primary health care at PATH to examine how cross-sector partnerships with entities such as the Sanofi Global Health Unit can break through acute financing bottlenecks. Addressing this systemic imbalance requires a fundamental shift in how resources are mobilized, integrated, and tracked: “Invest more, invest better, and invest transparently — that’s really the future of better investing.”

Read the full Q&A to explore how primary healthcare can drive sustainable NCD financing: https://dvx.cm/ena04p

Globally, approximately 64% of people with hepatitis C virus (HCV) and 12% of people with HIV are unaware of their statu...
10/13/2026

Globally, approximately 64% of people with hepatitis C virus (HCV) and 12% of people with HIV are unaware of their status. The World Health Organization (WHO) recommends self-testing as a powerful and effective approach toward HCV elimination.

PATH, with support from Unitaid, has combined targeted research, global policy and guideline development, and active market creation to successfully increase self-testing worldwide. From rapid scale-up of HIV self-testing in India, Indonesia, and Uganda to piloting the first-ever use of HCV self-testing in harm reduction settings in Ukraine, we are showing what is possible in providing individuals with greater autonomy and control over their own health care.

💡 Want to learn more? Join us this Thursday, Oct 15. We’ll be sharing key lessons in a WHO-PSI webinar, "Scaling What Works: The Role of Self-Testing in Reclaiming HCV Elimination Goals."

🗓️ Click here to register: https://bit.ly/3WmgTuw

Effective disease surveillance starts with strong connections between communities and health teams. During the response...
10/13/2026

Effective disease surveillance starts with strong connections between communities and health teams.

During the response to the 17th Ebola outbreak in Bas-Uélé Province, DRC, PATH’s STRengthening Infectious disease DEtection Systems (STRIDES) team worked alongside local health authorities, community health workers, youth leaders, motorcycle taxi associations, media professionals, and civil society representatives to strengthen Ebola detection and contact tracing.

STRIDES supported the training of 109 community health workers and engaged community networks across the Buta Health Zone.

In just two weeks:

âś… Alerts increased from 248 to 461
âś… Contact tracing follow-up increased from 63.3% to 70.4%
âś… 38 of 44 contacts lost to follow-up were found

These results show how close collaboration can help close gaps in surveillance and strengthen the response to Ebola.

The STRIDES activity is funded by the US government, led by FHI 360, with PATH and Black & Veatch as core partners.

Learn more about PATH's Ebola response: https://bit.ly/4dpjBoV

Introducing the vaccine is only step one. Ensuring that children receive all four doses is the real challenge. After t...
10/12/2026

Introducing the vaccine is only step one. Ensuring that children receive all four doses is the real challenge.

After the vaccine was introduced in 2024, many children in Mozambique’s Zambézia Province received their first dose but didn’t return for subsequent doses.

To help families understand the malaria vaccine schedule, identify children who had missed doses, and connect them with opportunities to catch up, we partnered with district health teams and trusted local health workers known as Agentes Polivalentes de SaĂşde (APS). We also worked with religious, traditional, and other local leaders to reach families.

Between November 2025 and June 2026, community members who attended our trainings:

Conducted more than 6,100 community talks

Completed nearly 75,000 household visits

Referred more than 1,100 children with incomplete vaccinations for follow-up

By linking awareness with follow-up and working through trusted community structures, district health teams helped families complete their children’s vaccination schedules and get the protection they need against malaria.

đź”—Learn more about this work in Mozambique: https://bit.ly/46ZDLCm

Today is , and if you have a donor-advised fund (DAF), it’s a chance to put those charitable dollars to work for the ca...
10/08/2026

Today is , and if you have a donor-advised fund (DAF), it’s a chance to put those charitable dollars to work for the causes you care about.

A longtime PATH supporter is leading the way, matching the first $10,000 in DAF grants to PATH. Your grant can go twice as far in bringing health innovations and lifesaving tools to more people in more communities around the world.

Recommend a DAF grant to PATH today and help us reach the match.

đź’–Give today: https://bit.ly/4dTp9rW

How do you get a vaccine to a health worker in a remote clinic and give them a way to know it still works? For PATH, the...
10/07/2026

How do you get a vaccine to a health worker in a remote clinic and give them a way to know it still works?

For PATH, the answer started with a frozen chicken.

Last week, PATH cofounder Rich Mahoney joined Taruni Roy Khurana, our Global Director of Programs and Impact, for an Inside Global Health conversation in Seattle with supporters, partners, and former colleagues.

Rich took us back to PATH's earliest days. He left a job at the Ford Foundation for a one-year contract in Manila, convinced that health solutions had to be developed with and for the people they serve.

He also told the story of Gordon Perkin, another PATH cofounder, who read about a temperature indicator used on frozen poultry and then went to a grocery store to see it for himself. That curiosity helped inspire the vaccine vial monitor, a small label that shows health workers whether a vaccine has been exposed to too much heat. Immunization programs around the world now rely on it.

Nearly 50 years later, the idea behind PATH still holds: a breakthrough only matters if it reaches the people who need it. Today, that work is moving closer to the countries and communities it serves, including through our regional digital and AI hubs.

Thank you, Rich, and thank you to everyone who joined us.

đź“© Interested in attending future Inside Global Health events? Email [email protected] to stay connected and hear about upcoming programs.

đź“Ł Attending INHSU 2026? Join us on October 8 for two sessions exploring how to deliver and scale long-acting depot bupre...
10/07/2026

đź“Ł Attending INHSU 2026? Join us on October 8 for two sessions exploring how to deliver and scale long-acting depot buprenorphine (LADB) in low-and middle-income countries (LMICs).

LADB can expand opioid agonist maintenance treatment (OAMT) options, giving people who inject drugs greater autonomy and flexibility, fewer dosing visits, and less disruption to daily life. It also has the potential to improve treatment continuity and retention, while supporting efforts to reduce viral hepatitis and HIV transmission.

Join us for:

🔵 From Evidence to Early Adoption: What will it take to deliver LADB access in LMICs? PATH and partners will share new implementation research findings, country readiness signals, and early market-shaping efforts to advance LADB access.

🔵 Client choice: Lessons and tools for promoting client choice from a global study into LADB in LMICs. Led by Coact Technical Support Ltd, this workshop will explore practical approaches to client literacy and choice in OAMT, drawing on tools and lessons from LADB research.

📍 Curated session: 11:15–12:15, Zenit Room

📍 Workshop: 4:00–5:30 PM, Leo + Virgo Room
đź”— Learn more: https://bit.ly/4dpygAp

Unitaid | London School of Hygiene & Tropical Medicine | University of Bristol | Population Services International | World Health Organization (WHO)

Hepatitis C (HCV) elimination requires health services that meet people where they are. Through the Unitaid-funded HepC3...
10/07/2026

Hepatitis C (HCV) elimination requires health services that meet people where they are.

Through the Unitaid-funded HepC3P project, PATH is piloting innovative models of care in India and Ukraine that integrate HCV prevention, testing, and treatment into trusted HIV, harm reduction, and prison health services.

Early results are encouraging, with high uptake of screening and treatment, promising opportunities for self-testing, and practical needle and syringe programs in prisons.

Most importantly, communities of people who inject drugs are helping design, deliver, and monitor these models, ensuring services reflect their needs and experiences.

As we share these findings at , learn how people-centered, community-led approaches can expand access to HCV services and help accelerate progress toward elimination.

đź”— https://bit.ly/4y94BTD

Address

437 N 34th Street
Seattle, WA
98103

Telephone

+12062853500

Website

Alerts

Be the first to know and let us send you an email when PATH posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category